当前位置: 首页 > 期刊 > 《中国当代医药》 > 2010年第8期
编号:12039526
MMP-2与甲状腺乳头状癌的研究进展(1)
http://www.100md.com 2010年3月15日 《中国当代医药》 2010年第8期
     [摘要] 甲状腺乳头状癌的治疗预后虽然较好,但是同样具有恶性肿瘤侵袭、转移的生物学特性。MMPs在肿瘤的侵袭、转移过程中发挥了重要的作用,尤其是其家族成员中的MMP-2(基质金属蛋白酶-2或明胶酶)的研究,提示在甲状腺乳头状癌组织中呈高阳性,高水平表达与良性病变有明显的统计学差异。本文结合近年来对MMP-2在甲状腺疾病中研究的国内外报道文献,综述MMP-2在甲状腺乳头状癌的研究状况,展望未来的研究方向。

    [关键词] MMP-2;甲状腺乳头状癌;MMP-2表达

    [中图分类号] R736.1 [文献标识码]A [文章编号]1674-4721(2010)03(b)-015-02

    The research progress of MMP-2 with papillary thyroid carcinoma

    HUANG Yong,CHENG Ruochuan

    (Department of Gastrointestinal and Thyroid Surgery, the First Affiliated Hospital of Kunming Medical College,Yunnan Province, Kunming650031, China)

    [Abstract] Treatment of prognosis of papillary thyroid carcinoma although the better, but it is also a m alignant tumor invasion and metastasis of biological characteristics .MMPs in tumor invasion and metastasis played an important role, especially its family members of the MMP-2 (matrix metalloproteinase -2 or gelatinase) the study, suggesting that in papillary thyroid carcinoma showed a high positive, high-level expression of benign lesions have statistically significant difference. In recent years with MMP-2 in thyroid diseases studied literature at home and abroad reported an overview of MMP-2 in thyroid papillary carcinoma of the research situation, look to the future research directions. ......
1 2下一页

您现在查看是摘要页,全文长 5633 字符